From: powerallpharmacy@gmail.com 
  
 KLONOPIN€€: (clonazepam) Tablets, for Oral Use 
  
 DESCRIPTION 
 Klonopin, a benzodiazepine, is available as scored tablets with a K-shaped 
 perforation containing 0.5 mg of clonazepam and unscored tablets with a 
 K-shaped perforation containing 1 mg or 2 mg of clonazepam. Each tablet also 
 contains lactose, magnesium 
 stearate, microcrystalline cellulose and corn starch, with the following 
 colorants: 0.5 mg€€€FD&C Yellow No. 6 Lake; 1 mg€€€FD&C Blue No. 1 Lake and 
 FD&C Blue No. 2 Lake. 
  
 Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4- 
 benzodiazepin-2-one. It is a light yellow crystalline powder. It has a 
 molecular weight of 315.72 
  
 INDICATIONS 
 Seizure Disorders 
 Klonopin is useful alone or as an adjunct in the treatment of the 
 Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic 
 seizures. 
 In patients with absence seizures (petit mal) who have failed to respond to 
 succinimides, Klonopin may be 
 useful. 
  
 Some loss of effect may occur during the course of clonazepam treatment (see 
 PRECAUTIONS: Loss Of Effect). 
  
 Panic Disorder 
 Klonopin is indicated for the treatment of panic disorder, with or without 
 agoraphobia, as defined in DSM-V. Panic disorder is characterized by the 
 occurrence of unexpected panic attacks and associated concern about having 
 additional attacks, worry about 
 the implications or consequences of the attacks, and/or a significant change 
 in behavior related to the attacks. 
  
 The efficacy of Klonopin was established in two 6- to 9-week trials in panic 
 disorder patients whose diagnoses corresponded to the DSM-III R category of 
 panic disorder (see Clinical Trials). 
  
 Panic disorder (DSM-V) is characterized by recurrent unexpected panic 
 attacks, 
 i.e., a discrete period of intense fear or discomfort in which four (or 
 more) 
 of the following symptoms develop abruptly and reach a peak within 10 
 minutes: 
 (1) palpitations, 
 pounding heart or accelerated heart rate; (2) sweating; (3) trembling or 
 shaking; (4) sensations of shortness of breath or smothering; (5) feeling of 
 choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) 
 feeling dizzy, unsteady, 
 lightheaded or faint; (9) derealization (feelings of unreality) or 
 depersonalization (being detached from oneself); (10) fear of losing 
 control; 
 (11) fear of dying; (12) paresthesias (numbness or tingling sensations); 
 (13) 
 chills or hot flushes. 
  
 The effectiveness of Klonopin in long-term use, that is, for more than 9 
 weeks, has not been systematically studied in controlled clinical trials. 
 The 
 physician who elects to use Klonopin for extended periods should 
 periodically 
 reevaluate the long-term 
 usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRA 
  
 HOW SUPPLIED 
 Klonopin tablets are available as scored tablets with a K-shaped 
 perforation 
  
 Imprint on tablets: 
 2 mg - 2 KLONOPIN (front) ROCHE (reverse side) 
  
 Store at 25€€C (77€€F); excursions permitted to 15€€ to 30€€C (59€€ to 
 86€€F) 
  
 For More Details: 
 https://www.powerallpharmacy.ca/index.php?main_page=product_info 
 cPath=1_9&products_id=31 
 Whatsapp: +1 (336) 267-4575 
  
 --- SoupGate-Win32 v1.05 
  * Origin: you cannot sedate... all the things you hate (1:229/2)